【摘要】 目的　比较流感亚单位疫苗与裂解疫苗的安全性和免疫原性。方法　流感亚单位疫苗和裂解疫苗按随机双盲法分别接种 2 4 9名和 2 50名 6～ 1 2岁健康儿童。于接种当日和接种后 3天内观察局部反应和全身反应。用血凝抑制试验检测接种儿童免疫前后的血凝抑制抗体 (HI)滴度 ,计算抗体 4倍增长阳转率 ,免疫后的保护水平抗体 (≥ 1∶40 )的免疫成功率 ,以及抗体几何平均滴度(GMT)值和增长倍数。比较流感亚单位疫苗和裂解疫苗的临床观察结果。结果　两种疫苗接种后均未见局部反应 ,发热反应率和中高度发热反应率亚单位疫苗低于裂解疫苗 ,两组的差异有显著的统计学意义。未见其他全身反应。对疫苗 3个毒株的血清学检测结果显示 :亚单位疫苗的阳转率为74.5 %～ 95 .1 % ,保护水平抗体的免疫成功率为 94.2 %～ 99.6 % ,抗体GMT增长倍数为 5 .4～ 2 1 .2。裂解疫苗的阳转率为 79.8%～ 97.8% ,保护水平抗体的免疫成功率为 96 .4%～ 1 0 0 .0 % ,抗体GMT增长倍数为 6 .4～ 2 1 .0。两种疫苗的免疫学效果相似 ,所见差异无显著的统计学意义。结论　流感亚单位疫苗和裂解疫苗接种 6～ 1 2岁儿童后反应轻微 ,安全性良好 ,亚单位疫苗发热反应率低于裂解疫苗。两种疫苗的免疫原性良好 ,具有同样显著的免疫效果 ,可以推广使用更多还原

【Abstract】 Objective To compare the reactogenicity and serology between influenza subunit vaccine and split vaccine. Methods A randomized, double blind study was carried out among children (age 6 12 years) in order to compare the safety and immunogenicity of an influenza inactivated subunit vaccine (Agrippal, Chiron Vaccines) with that of a split vaccine (Flurix, GSK). Results A total of 499 subjects were vaccinated and included in the safety analysis. A total of 249 subjects received Agrippal and 250 received Flurix. All subjects were kept under medical observation for 30 minutes in order to check the evidence of having any immediate local and systemic reaction. Daily observation records were collected during the 3 day follow up after vaccination. 6.4% of the cases with fever ≥ 37.5 ℃ was reported in the Flurix group, but 2.4% in Agrippal group which was significantly less than the former group ( P > 0.05 ). Blood samples (the D0 pre and D23 post vaccination sera) were collected from 224 of Agrippal group and 223 of Flurix group and analysed by the haemagglutination inhibition (HI) assay. Agrippal and Flurix induced similar seroprotection (HI titer ≥1∶40 , H1N1 99.6 % vs 100.0 %; H3N2 99.1 % vs 99.1 %) and seroconversion (4 fold increase, 95.1 % vs 97.8 %; H3N2 74.5 % vs 79.8 %) rates and geometric mean titer (GMT) increase ( 16.0 vs 21.0 ; 5.4 vs 6.4 ) against the two A subtypes. A similar seroprotection rate ( 94.2 % vs 96.4 %) and GMT increase ( 21.2 vs 18.2 ) against the influenza B strain were also noticed in both vaccines. No significant difference was found in the results of immunological assay between the two vaccines ( P < 0.05 ). A lower seroconversion rate against B strain was observed in Agrippal group than in Flurix group ( 91.1 % vs 97.3 %). Conclusion In terms of safety, both vaccines were generally well tolerated. The fever reaction was less frequently seen in the Agrippal group. Both vaccines induced an effective immune response in the vaccines.更多还原